- Home
- LPCN vs SOHO Comparison
LPCN vs SOHO Comparison
Compare LPCN & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- SOHO
- Stock Information
- Founded
- LPCN 1997
- SOHO 2004
- Country
- LPCN United States
- SOHO United States
- Employees
- LPCN N/A
- SOHO N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- SOHO Real Estate Investment Trusts
- Sector
- LPCN Health Care
- SOHO Real Estate
- Exchange
- LPCN Nasdaq
- SOHO Nasdaq
- Market Cap
- LPCN 16.1M
- SOHO 16.3M
- IPO Year
- LPCN N/A
- SOHO 2004
- Fundamental
- Price
- LPCN $3.10
- SOHO $0.74
- Analyst Decision
- LPCN Strong Buy
- SOHO Hold
- Analyst Count
- LPCN 1
- SOHO 1
- Target Price
- LPCN $10.00
- SOHO $1.50
- AVG Volume (30 Days)
- LPCN 10.3K
- SOHO 52.3K
- Earning Date
- LPCN 05-08-2025
- SOHO 05-13-2025
- Dividend Yield
- LPCN N/A
- SOHO N/A
- EPS Growth
- LPCN N/A
- SOHO N/A
- EPS
- LPCN N/A
- SOHO N/A
- Revenue
- LPCN $11,198,144.00
- SOHO $180,394,287.00
- Revenue This Year
- LPCN N/A
- SOHO $13.93
- Revenue Next Year
- LPCN N/A
- SOHO N/A
- P/E Ratio
- LPCN N/A
- SOHO N/A
- Revenue Growth
- LPCN N/A
- SOHO 3.91
- 52 Week Low
- LPCN $2.75
- SOHO $0.59
- 52 Week High
- LPCN $11.79
- SOHO $1.54
- Technical
- Relative Strength Index (RSI)
- LPCN 46.56
- SOHO 54.72
- Support Level
- LPCN $2.82
- SOHO $0.70
- Resistance Level
- LPCN $3.27
- SOHO $0.79
- Average True Range (ATR)
- LPCN 0.23
- SOHO 0.07
- MACD
- LPCN 0.01
- SOHO 0.01
- Stochastic Oscillator
- LPCN 58.92
- SOHO 72.90
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.